The search for a blood-based biomarker for Alzheimer disease

Nature Reviews Neurology

Volumn 10, Issue 11, 2014, Pages 618-619

  Rembach, Alan ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; C C MOTIF CHEMOKINE 5; CHEMOKINE; CLUSTERIN; NEURON SPECIFIC ENOLASE; PREALBUMIN; UNCLASSIFIED DRUG; PLASMA PROTEIN;

ALZHEIMER DISEASE; ASYMPTOMATIC DISEASE; BLOOD EXAMINATION; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; LONGITUDINAL STUDY; MASS SCREENING; MILD COGNITIVE IMPAIRMENT; PROGNOSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; BLOOD; DEMENTIA; FEMALE; MALE; METABOLISM; PRODROMAL SYMPTOM;

BLOOD PROTEINS; DEMENTIA; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS;

EID: 84908555662     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.182     Document Type: Review

References (9)

1. Ray, S. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359-1362 (2007).
2. Hye, A. et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. http:// dx.doi.org/10.1016/j.jalz.2014.05.1749.
3. Villemagne, V. L. et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 12, 357-367 (2013).
4. Hye, A. et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129, 3042-3050 (2006).
5. O'Bryant, S. E. et al. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS ONE 6, e28092 (2011).
6. Laws, S. M., Doecke, J. D. & Martins, R. N. Blood-based biomarkers in Alzheimer disease: where are we now and where have we to go? -Reply. JAMA Neurol. 70, 133-134 (2013).
7. Burnham, S. C. et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Mol. Psychiatry 19, 519-526 (2014).
8. Soares, H. D. et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol. 69, 1310-1317 (2012).
9. Skogstrand, K. Multiplex assays of inflammatory markers, a description of methods and discussion of precautions -our experience through the last ten years. Methods 56, 204-212 (2012).